0001209191-21-015846.txt : 20210302
0001209191-21-015846.hdr.sgml : 20210302
20210302160654
ACCESSION NUMBER: 0001209191-21-015846
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210226
FILED AS OF DATE: 20210302
DATE AS OF CHANGE: 20210302
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KNIGHT SUSAN E
CENTRAL INDEX KEY: 0001183157
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-23837
FILM NUMBER: 21703570
MAIL ADDRESS:
STREET 1: 9154 BRECKENRIDGE LANE
CITY: EDEN PRAIRIE
STATE: MN
ZIP: 55437
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SURMODICS INC
CENTRAL INDEX KEY: 0000924717
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 411356149
STATE OF INCORPORATION: MN
FISCAL YEAR END: 0930
BUSINESS ADDRESS:
STREET 1: 9924 W 74TH ST
CITY: EDEN PRAIRIE
STATE: MN
ZIP: 55344
BUSINESS PHONE: 9525007000
MAIL ADDRESS:
STREET 1: 9924 WEST 74TH ST
CITY: EDEN PRAIRIE
STATE: MN
ZIP: 55344
FORMER COMPANY:
FORMER CONFORMED NAME: BSI CORP
DATE OF NAME CHANGE: 19970506
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-02-26
0
0000924717
SURMODICS INC
SRDX
0001183157
KNIGHT SUSAN E
9154 BRECKENRIDGE LANE
EDEN PRAIRIE
MN
55437
1
0
0
0
Common Stock
2021-02-26
4
M
0
5576
21.31
A
34290
D
Common Stock
2021-02-26
4
S
0
5576
52.3593
D
28714
D
Stock Option (right to buy)
21.31
2021-02-26
4
M
0
5576
0.00
D
2021-12-03
Common Stock
5576
0
D
Reflects the weighted average price of 5,576 shares of common stock of Surmodics, Inc. sold by the reporting person in multiple transactions on February 26, 2021 with sale prices ranging from $51.93 to $52.69 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
The amount beneficially owned includes 11,721 restricted stock units (RSUs) that vest on service-based vesting dates that will be settled in shares of the issuer's common stock on a 1 for 1 basis when the reporting person's service as a director ends.
Fully vested.
/s/ John Manders, on behalf of Susan E. Knight
2021-03-02